These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32276083)

  • 1. Lifestyle and risk factor modification for reduction of atrial fibrillation: We could do more.
    Guo Y; Lip GYH; Lane DA
    Trends Cardiovasc Med; 2020 Aug; 30(6):387-388. PubMed ID: 32276083
    [No Abstract]   [Full Text] [Related]  

  • 2. New concepts in the therapy of atrial fibrillation.
    Cocco G; Jerie P
    Cardiol J; 2016; 23(1):3-11. PubMed ID: 26412599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on atrial fibrillation.
    Khaji A; Kowey PR
    Trends Cardiovasc Med; 2017 Jan; 27(1):14-25. PubMed ID: 27520496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MY APPROACH to a patient with atrial fibrillation and dementia.
    Bunch J
    Trends Cardiovasc Med; 2016 Apr; 26(3):293-4. PubMed ID: 26868453
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of postoperative atrial fibrillation: The long road ahead.
    Hui DS; Lee R
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1840-1843. PubMed ID: 31358335
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathophysiological consequences of the EAST-AFNET4 trial: AF is not an innocent bystander.
    Goette A
    Cardiovasc Res; 2020 Dec; 116(14):e200-e201. PubMed ID: 33205206
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial commentary: Atrial fibrillation and dementia: Time to reconsider the therapy outcomes relevant for patients?
    Lyan E; Demming T; Frank D
    Trends Cardiovasc Med; 2024 May; 34(4):242-243. PubMed ID: 36813252
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atrial fibrillation].
    Tilz RR; Kuck KH
    Herz; 2015 Feb; 40(1):7. PubMed ID: 25645236
    [No Abstract]   [Full Text] [Related]  

  • 9. Atrial Fibrillation, Past and Future: From a Stroke Non-Entity to an Over-Targeted Cause.
    Caplan LR
    Cerebrovasc Dis; 2018; 45(3-4):149-153. PubMed ID: 29587270
    [No Abstract]   [Full Text] [Related]  

  • 10. Beyond cardioversion, ablation and pharmacotherapies: Risk factors, lifestyle change and behavioral counseling strategies in the prevention and treatment of atrial fibrillation.
    Mehta NK; Strickling J; Mark E; Swinehart S; Puthumana J; Lavie CJ; Haines DE; Franklin BA
    Prog Cardiovasc Dis; 2021; 66():2-9. PubMed ID: 34023354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing atrial fibrillation in the very elderly patient: challenges and solutions.
    Karamichalakis N; Letsas KP; Vlachos K; Georgopoulos S; Bakalakos A; Efremidis M; Sideris A
    Vasc Health Risk Manag; 2015; 11():555-62. PubMed ID: 26604772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [2010 AIAC Guidelines for the management and treatment of atrial fibrillation].
    Raviele A; Disertori M; Alboni P; Bertaglia E; Botto G; Brignole M; Cappato R; Capucci A; Del Greco M; De Ponti R; Di Biase M; Di Pasquale G; Gulizia M; Lombardi F; Themistoclakis S; Tritto M;
    G Ital Cardiol (Rome); 2011 Jan; 12(1 Suppl 1):7-69. PubMed ID: 22624161
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nonrheumatic atrial fibrillation. Rhythm conversion or anticoagulation?].
    Lengfelder W; Senges J
    Dtsch Med Wochenschr; 1992 Mar; 117(13):505-10. PubMed ID: 1551376
    [No Abstract]   [Full Text] [Related]  

  • 14. Atrial fibrillation.
    Falk RH
    N Engl J Med; 2001 Apr; 344(14):1067-78. PubMed ID: 11287978
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment: special conditions: co-existing heart disease: atrial fibrillation.
    Arora R; Yancy CW
    J Am Soc Hypertens; 2015 Apr; 9(4):313-7; quiz 318-9. PubMed ID: 25753300
    [No Abstract]   [Full Text] [Related]  

  • 16. Atrial fibrillation.
    Nijjer SS; Lefroy DC
    Br J Hosp Med (Lond); 2012 May; 73(5):C69-73. PubMed ID: 22585291
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study.
    Jiang C; Lan DH; Du X; Geng YP; Chang SS; Zheng D; Chen JB; Yu RH; Sang CH; Long DY; Tang RB; Zhou YC; Min Y; Lu Y; Dong JZ; Lip GYH; Ma CS
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2759-2766. PubMed ID: 31599040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations on stroke in atrial fibrillation despite anticoagulation.
    Di Giosia P; Giorgini P; Ferri C
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e54-e57. PubMed ID: 29538145
    [No Abstract]   [Full Text] [Related]  

  • 19. HFREF Patients and Atrial Fibrillation: Time to Reconsider the Appropriateness of the Atrial Fibrillation Ablation in This Patient Subset?
    De Vecchis R
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):383-384. PubMed ID: 30955171
    [No Abstract]   [Full Text] [Related]  

  • 20. Current Evidence-Based Understanding of the Epidemiology, Prevention, and Treatment of Atrial Fibrillation.
    Rogers PA; Bernard ML; Madias C; Thihalolipavan S; Mark Estes NA; Morin DP
    Curr Probl Cardiol; 2018 Jun; 43(6):241-283. PubMed ID: 29759117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.